Company / Gross Profit
Harmony Biosciences Holdings, Inc. Gross Profit History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$670.1M
FY2025
5-year range
$4.4M / $670.1M
FY2021-FY2025
Trend
+20.1%
vs FY2024
Sector context
#11 of 29
Health Care
What the data says
At $670M, Harmony Biosciences Holdings, Inc.'s gross profit ranks #11 of 29 in the Health Care sector. Gross Profit has increased for 4 consecutive years, from $4M in FY2021 to $670M in FY2025.
Based on SEC 10-K filings.
$670M in FY2025 with a 5-year CAGR of +173.0%.
Improved from $461M to $670M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- +173.0%
- 10-Year CAGR
- -
Sector benchmark
#11 of 29 in Health CareTop 38% of 29This company $670.1M Sector average $3.5B
▼
-80.6% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s gross profit has grown for 4 consecutive years.
- 5-year CAGR of +173.0%, indicating consistent growth.
- In FY2025, gross profit increased 20.1% year-over-year.
- Ranks #11 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $670.1M | +20.1% |
| FY2024 | $557.9M | +21.1% |
| FY2023 | $460.8M | +30.0% |
| FY2022 | $354.4M | +7921.1% |
| FY2021 | $4.4M | +0.0% |
| FY2020 | $4.4M | +0.0% |
| FY2019 | $4.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026